Parkinson’s Disease Psychosis: Symptoms, Management, and Economic Burden
Volume: 21
Issue: 10 Suppl
The Evolving Treatment Landscape and Innovative Payment Models in Oncology: An Expert Summit
Reductions in Mortality Among Medicare Beneficiaries Following the Implementation of Medicare Part D
Issue: 9 Suppl
Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
Issue: 8 Suppl
ADA 2015 Conference Coverage
Special Issue: Product Pipeline Review [June]
The Evidence Behind the Evidence: A Deeper Dive Into the Management of Chronic Heart Failure
Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Issue: 7 Suppl
Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]
Issue: 6 Suppl
Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Issue: 5 Suppl
Economic Evaluation of a Fluocinolone Acetonide Intravitreal Implant for Patients With DME Based on
Issue: 4 Suppl
Characterizing Pulmonary Hypertension–Related Hospitalization Costs Among Medicare Advantage or Co
Issue: 3 Suppl
Standards of Care Issues With Anticoagulation in Real-World Populations
Issue: 2 Suppl
Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]
Issue: 1 Suppl
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Volume: 20
Issue: 14 Suppl
Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Anal
Issue: 13 Suppl
Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]
Issue: 12 Suppl
Implications for Multiple Sclerosis in the Era of the Affordable Care Act: A Clinical and Managed Ca
Issue: 11 Suppl
Evidence-Based Cardiology - December
Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era
Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus
Evidence-Based Cardiology - October
ADA 2014 Conference Coverage
Balancing Therapeutic Safety and Efficacy to Improve Clinical and Economic Outcomes in Schizophrenia
Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: New Guidelines, Therapies, and
Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imagi
Improving Transitions of Care for Patients With Thromboembolic Disease
Practical Perspectives on the Management of Overweight and Obesity
Evolving Strategies for the Management of Multiple Myeloma: A Managed Care Perspective